Top Managed Futures News, Listings, Member Posts, Managed Futures Daily Indices and more!

3yrs ago Managed Futures futuresmag Views: 327



Like Monday, rally attempts in the S&P and Nasdaq were deflected by strong levels of technical resistance. From there, each bled slowly leading up to the final hour. Late last night, a U.S. health agency questioned the validity of AstraZeneca’s vaccine trials, saying the results included outdated data. To make matters worse, Germany followed through and announced a strict 5-day lockdown over Easter.The vaccine was suspended throughout the EU after concerns it caused blood clots. Trials across the U.S., Chile, and Peru showed the vaccine 79% effective with no link to blood clots. This comes after the European Medicines Agency confirmed similar findings last Thursday.The Treasury complex responded to the Fed’s emphasis on underemployment and how their expectations of only a meager increase in Core PCE to 2.0-2.2% through 2023 will keep policy accommodative.It’s Fed Day: the committee’s policy decision, economic outlook, and interest rate projections are due at 1:00 p.m. CT. Yields of longer duration Treasuries are climbing as many analysts say a dovish Fed is simply not enough anymore.Is emphasis on “remaining accommodative” merely enough now? Markets want to hear something on the steeping yield curve. They've become accustomed to continued assistance and yield curve control is now what they’re asking for.U.S. benchmarks were little changed ahead of Monday’s opening bell. The easing of state and local restrictions coupled with Congress passing President Biden’s fiscal package has brought a continued tailwind to many sectors.The ECB said it’d purchase bonds at a faster pace through its PEPP program and that it expects yields to remain at their current levels or lower.Gains of about 4% for each Apple, Facebook, and Amazon, a whopping 20% for Tesla, and the best day in nearly a year for semiconductors brought the S&P and Nasdaq to critical levels of technical resistance.The Treasury complex is certainly aiding the rebound as the 10-year Note backs off to 1.53% from a high of 1.62%, ahead of a deluge of auctions through the next 3 days. 

Today's Managed Futures Headlines:

Log In for More
Access Over 250K+ Industry Headlines, Posts and Updates
Not a member yet?

Join AlphaMaven

The Premier Alternative Investment
Research and Due Diligence Platform for Investors

Free Membership for Qualified Investors and Industry Participants
  • Easily Customize Content to Match Your Investment Preferences
  • Breaking News 24/7/365
  • Daily Newsletter & Indices
  • Alternative Investment Listings & LeaderBoards
  • Industry Research, Due Diligence, Videos, Webinars, Events, Press Releases, Market Commentary, Newsletters, Fact Sheets, Presentations, Investment Mandates, Video PitchBooks & More!
  • Company Directory
  • Contact Directory
  • Member Posts & Publications
  • Alpha University Video Series to Expand Investor Knowledge
  • AUM Accelerator Program (designed for investment managers)
  • Over 450K+ Industry Headlines, Posts and Updates
ALL ALPHAMAVEN CONTENT IS FOR INFORMATIONAL PURPOSES ONLY. CONTENT POSTED BY MEMBERS DOES NOT NECESSARILY REFLECT THE OPINION OR BELIEFS OF ALPHAMAVEN AND HAS NOT ALWAYS BEEN INDEPENDENTLY VERIFIED BY ALPHAMAVEN. PAST PERFORMANCE IS NOT INDICATIVE OF FUTURE RESULTS. THIS IS NOT A SOLICITATION FOR INVESTMENT. THE MATERIAL PROVIDED HEREIN IS FOR INFORMATIONAL PURPOSES ONLY. IT DOES NOT CONSTITUTE AN OFFER TO SELL OR A SOLICITATION OF AN OFFER TO BUY ANY INTERESTS OF ANY FUND OR ANY OTHER SECURITIES. ANY SUCH OFFERINGS CAN BE MADE ONLY IN ACCORDANCE WITH THE TERMS AND CONDITIONS SET FORTH IN THE INVESTMENT'S PRIVATE PLACEMENT MEMORANDUM. PRIOR TO INVESTING, INVESTORS ARE STRONGLY URGED TO REVIEW CAREFULLY THE PRIVATE PLACEMENT MEMORANDUM (INCLUDING THE RISK FACTORS DESCRIBED THEREIN), THE LIMITED PARTNERSHIP AGREEMENT AND THE SUBSCRIPTION DOCUMENTS, TO ASK SUCH QUESTIONS OF THE INVESTMENT MANAGER AS THEY DEEM APPROPRIATE, AND TO DISCUSS ANY PROSPECTIVE INVESTMENT IN THE FUND WITH THEIR LEGAL AND TAX ADVISERS IN ORDER TO MAKE AN INDEPENDENT DETERMINATION OF THE SUITABILITY AND CONSEQUENCES OF AN INVESTMENT.